USD 0.98
(-11.71%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 494.37 Thousand USD | 14.84% |
2022 | 430.49 Thousand USD | 11.04% |
2021 | 387.68 Thousand USD | 33.9% |
2020 | 289.53 Thousand USD | 52.26% |
2019 | 190.15 Thousand USD | -21.12% |
2018 | 241.06 Thousand USD | -9.05% |
2017 | 265.04 Thousand USD | -2.63% |
2016 | 272.2 Thousand USD | 17.46% |
2015 | 231.74 Thousand USD | -36.92% |
2014 | 367.36 Thousand USD | 200.69% |
2013 | 122.17 Thousand USD | -15.86% |
2012 | 145.2 Thousand USD | 48.77% |
2011 | 97.6 Thousand USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 441.71 Thousand USD | -10.65% |
2024 Q2 | 568.21 Thousand USD | 28.64% |
2023 FY | 494.37 Thousand USD | 14.84% |
2023 Q4 | 494.37 Thousand USD | 12.36% |
2023 Q3 | 439.98 Thousand USD | 11.76% |
2023 Q2 | 393.69 Thousand USD | 3.53% |
2023 Q1 | 380.29 Thousand USD | -11.66% |
2022 FY | 430.49 Thousand USD | 11.04% |
2022 Q4 | 430.49 Thousand USD | -12.81% |
2022 Q3 | 493.72 Thousand USD | 4.03% |
2022 Q2 | 474.61 Thousand USD | 4.16% |
2022 Q1 | 455.68 Thousand USD | 17.54% |
2021 Q4 | 387.68 Thousand USD | -2.59% |
2021 FY | 387.68 Thousand USD | 33.9% |
2021 Q3 | 397.97 Thousand USD | 25.22% |
2021 Q1 | 292.82 Thousand USD | 1.14% |
2021 Q2 | 317.82 Thousand USD | 8.54% |
2020 Q1 | 155.68 Thousand USD | -18.13% |
2020 Q3 | 205.9 Thousand USD | -12.52% |
2020 Q4 | 289.53 Thousand USD | 40.61% |
2020 Q2 | 235.36 Thousand USD | 51.18% |
2020 FY | 289.53 Thousand USD | 52.26% |
2019 Q3 | 210.35 Thousand USD | -34.45% |
2019 Q2 | 320.87 Thousand USD | 11.02% |
2019 FY | 190.15 Thousand USD | -21.12% |
2019 Q1 | 289.02 Thousand USD | 19.89% |
2019 Q4 | 190.15 Thousand USD | -9.6% |
2018 Q2 | 244.66 Thousand USD | -10.23% |
2018 Q1 | 272.55 Thousand USD | 2.83% |
2018 Q3 | 278.15 Thousand USD | 13.69% |
2018 Q4 | 241.06 Thousand USD | -13.33% |
2018 FY | 241.06 Thousand USD | -9.05% |
2017 Q4 | 265.04 Thousand USD | 10.95% |
2017 FY | 265.04 Thousand USD | -2.63% |
2017 Q3 | 238.88 Thousand USD | -1.37% |
2017 Q2 | 242.2 Thousand USD | -2.8% |
2017 Q1 | 249.18 Thousand USD | -8.46% |
2016 FY | 272.2 Thousand USD | 17.46% |
2016 Q1 | 256.53 Thousand USD | 10.7% |
2016 Q4 | 272.2 Thousand USD | -5.89% |
2016 Q3 | 289.24 Thousand USD | -1.0% |
2016 Q2 | 292.16 Thousand USD | 13.89% |
2015 Q4 | 231.74 Thousand USD | -2.17% |
2015 Q3 | 236.89 Thousand USD | -8.06% |
2015 Q2 | 257.66 Thousand USD | -14.51% |
2015 FY | 231.74 Thousand USD | -36.92% |
2015 Q1 | 301.38 Thousand USD | -17.96% |
2014 Q3 | 315.62 Thousand USD | -12.49% |
2014 Q1 | 391.56 Thousand USD | 220.5% |
2014 FY | 367.36 Thousand USD | 200.69% |
2014 Q2 | 360.66 Thousand USD | -7.89% |
2014 Q4 | 367.36 Thousand USD | 16.4% |
2013 Q4 | 122.17 Thousand USD | 20.89% |
2013 Q1 | 141.44 Thousand USD | -2.59% |
2013 Q2 | 108.03 Thousand USD | -23.62% |
2013 Q3 | 101.06 Thousand USD | -6.45% |
2013 FY | 122.17 Thousand USD | -15.86% |
2012 Q4 | 145.2 Thousand USD | 8.03% |
2012 Q2 | 96.79 Thousand USD | 5.28% |
2012 Q1 | 91.93 Thousand USD | -5.81% |
2012 FY | 145.2 Thousand USD | 48.77% |
2012 Q3 | 134.41 Thousand USD | 38.87% |
2011 Q2 | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2011 FY | 97.6 Thousand USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 Q4 | 97.6 Thousand USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q4 | - USD | -100.0% |
2009 Q3 | 10.86 Thousand USD | 0.0% |
2008 FY | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Akoya Biosciences, Inc. | 17.87 Million USD | 97.235% |
AngioDynamics, Inc. | 60.61 Million USD | 99.184% |
AtriCure, Inc. | 67.89 Million USD | 99.272% |
Avinger, Inc. | 5.29 Million USD | 90.669% |
Azenta, Inc. | 128.19 Million USD | 99.614% |
BioLife Solutions, Inc. | 43.45 Million USD | 98.862% |
The Cooper Companies, Inc. | 735.6 Million USD | 99.933% |
Daxor Corporation | - USD | -Infinity% |
Ekso Bionics Holdings, Inc. | 5.05 Million USD | 90.21% |
Femasys Inc. | 667.11 Thousand USD | 25.894% |
GlucoTrack, Inc. | - USD | -Infinity% |
Harvard Bioscience, Inc. | 24.71 Million USD | 98.0% |
Hologic, Inc. | 679.8 Million USD | 99.927% |
ICU Medical, Inc. | 709.36 Million USD | 99.93% |
Intuitive Surgical, Inc. | 1.22 Billion USD | 99.959% |
KORU Medical Systems, Inc. | 3.48 Million USD | 85.799% |
LeMaitre Vascular, Inc. | 52.33 Million USD | 99.055% |
Innovative Eyewear, Inc. | 856.75 Thousand USD | 42.297% |
Innovative Eyewear, Inc. | 856.75 Thousand USD | 42.297% |
Masimo Corporation | 545 Million USD | 99.909% |
Microbot Medical Inc. | - USD | -Infinity% |
Meihua International Medical Technologies Co., Ltd. | 1.61 Million USD | 69.431% |
Merit Medical Systems, Inc. | 303.87 Million USD | 99.837% |
Nephros, Inc. | 2.47 Million USD | 79.985% |
NovoCure Limited | 38.15 Million USD | 98.704% |
NEXGEL, Inc. | 1.31 Million USD | 62.519% |
NEXGEL, Inc. | 1.31 Million USD | 62.519% |
Singular Genomics Systems, Inc. | 13.57 Million USD | 96.357% |
OraSure Technologies, Inc. | 47.61 Million USD | 98.962% |
Pro-Dex, Inc. | 15.26 Million USD | 96.762% |
Pulse Biosciences, Inc. | - USD | -Infinity% |
Precision Optics Corporation, Inc. | 2.86 Million USD | 82.763% |
QuidelOrtho Corporation | 577.8 Million USD | 99.914% |
Repligen Corporation | 202.32 Million USD | 99.756% |
Sanara MedTech Inc. | 4.71 Million USD | 89.52% |
STAAR Surgical Company | 35.13 Million USD | 98.593% |
Sharps Technology, Inc. | 1.7 Million USD | 71.075% |
Utah Medical Products, Inc. | 9.58 Million USD | 94.841% |
DENTSPLY SIRONA Inc. | 624 Million USD | 99.921% |
Jin Medical International Ltd. | 5.05 Million USD | 90.216% |